Questioned by Wang Sicong, the 60 billion big bull stock Yiling Pharmaceutical responded again: never said WHO recommended Lianhua Qingwen

A few days ago, Wang Sicong questioned the efficacy of Yiling Pharmaceutical’s Lianhua Qingwen on Weibo, which caused heated discussions on the Internet.670fell to around 100 million600100 million.

The secretary of Yiling Pharmaceutical has responded to the question before, saying, “Regarding the news on Weibo, please point out the specific problem and source, and we will answer the specific content. From clinical trials to specific experimental data , and then to be included in the new coronary pneumonia diagnosis and treatment plan, including indications and instructions, we have complete evidence and report disclosure.

Just because of the three words ‘Wang Sicong’, you can’t ask questions at will. For some remarks on the Internet, just listen to them. Investors please screen them. “

Now Yiling Pharmaceutical has once again responded to the issue of Lianhua Qingwen’s treatment of new coronary pneumonia, the relevant person in charge of Yiling Pharmaceutical stated to “Chinese Entrepreneur”: “The company has never said on any occasion that ‘WHO recommends Lianhuaqing’ plague’”.

According to the “Securities Times” report, at 13:08 on April 14, Wang Sicong forwarded a message about Lianhua Qingwen Capsules on Weibo, saying that the regulatory authorities should strictly investigate Yiling Pharmaceutical.

About an hour later, Wang Sicong edited the Weibo again, deleting the words that the regulatory authorities should strictly investigate Yiling Pharmaceutical.

Hashtags: Wang Sicong’s new crown pneumonia, traditional Chinese medicine, traditional Chinese medicine